Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioTime, Inc. (NY: BTX)
4.230 USD  +0.040 (+0.95%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about BioTime, Inc.
 
< Previous 1 2 Next >
Could We Be in a Blossoming Market?
April 30, 2013
The 6 W’s: Who, what, where, when, why and what of it RegMed stocks were almost evenly split at mid-day, as financing announcements take center stage.  Along with slight increases in investor optimism... Read More
category Henry McCusker
from Bio-Wire.Com
LifeMap Sciences Announces Partnership With Appistry
April 23, 2013
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE: BTX ), announced today a collaborative partnership and value-added reseller agreement with Appistry, Inc., which provides big-data computing... Read More
category Benzinga , BTX , News
from Latest Articles from Benzinga.com
BioTime Announces License Deal with UCLA
April 19, 2013
BioTime, Inc. (NYSE: BTX ) today announced that it has entered into an exclusive license agreement with the University of California, Los Angeles (UCLA) for novel technology related to the treatment of... Read More
category Contracts , Benzinga , BTX , and 1 more.
from Latest Articles from Benzinga.com
Companies that Can Mend the Biotech Market: Stephen Brozak
April 11, 2013
Companies that Can Mend the Biotech Market: Stephen Brozak Source: George S. Mack of The Life Sciences Report (4/11/13) http://www.thelifesciencesreport.com/pub/na/15141 Markets are not efficient?at... Read More
category BTX , ASTM , ALXA , and 9 more.
from Bio-Wire.Com
LifeMap Sciences Adds Products Through Partnership with ProSpec-Tany TechnoGene
April 10, 2013
LifeMap Sciences, Inc., a subsidiary of BioTime (NYSE: BTX ), announced today that it is now offering 100 selected ProSpec-Tany TechnoGene (ProSpec) manufactured recombinant proteins related to stem... Read More
category Contracts , Benzinga , BTX , and 1 more.
from Latest Articles from Benzinga.com
BioTime's LifeMap Sciences Launches LifeMap Discovery Version 1.1
March 25, 2013
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE: BTX ), announced today the release of LifeMap Discovery^TM version 1.1 (discovery.lifemapsc.com). LifeMap Discovery^TM is a key component in... Read More
category Benzinga , BTX , News
from Latest Articles from Benzinga.com
BioTime, Inc. (BTX) Widens Q4 Loss to 12c/Share
March 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8194126 for the full story. Read More
from StreetInsider.com News Articles
BioTime (BTX) Unit Updates on Plans for PanC-Dx Development
January 31, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8046818 for the full story. Read More
from StreetInsider.com News Articles
4 Biotechnology Stocks to Sell Now
January 09, 2013
 Read More
category Stocks to Sell , NASDAQ:IMGN , NASDAQ:PGNX , and 2 more.
from InvestorPlace - Latest Headlines
Top Narrow Based Indexes For January 8, 2013
January 08, 2013
By 11:20 am, the Dow Jones Industrial Average was down 54.02 points, or 0.40%, to 13,330.27, while the broader Standard & Poor's 500 index had dropped 7.73 points, or 0.53%. The NASDAQ composite index... Read More
category Benzinga , Movers , FREE , and 9 more.
from Latest Articles from Benzinga.com
BioTime (BTX) Opens Higher After Announcing Agreement With Geron (GERN)
January 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7990114 for the full story. Read More
from StreetInsider.com News Articles
BioTime to Buy Human Embryonic Stem Cell Program Assets of Geron
January 07, 2013
BioTime, Inc. (NYSE: BTX ) and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a definitive Asset Contribution Agreement with... Read More
category Benzinga , US3741631036 , Asset Sales , and 5 more.
from Latest Articles from Benzinga.com
4 Biotechnology Stocks to Sell Now
December 27, 2012
 Read More
category Stocks to Sell , NASDAQ:IMGN , NASDAQ:PGNX , and 2 more.
from InvestorPlace - Latest Headlines
Benzinga's Small Cap Movers for Monday November 19, 2012
November 19, 2012
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: Grupo Casa Saba Shares of Grupo Casa Saba (NYSE: SAB ), the Mexican distributors of pharmaceutical... Read More
category Benzinga , Movers , Global , and 13 more.
from Latest Articles from Benzinga.com
Top Narrow Based Indexes For November 19, 2012
November 19, 2012
By 10:12 am, the Dow Jones Industrial Average was up 144.18 points, or 1.15%, to 12,732.49, while the broader Standard & Poor's 500 index had gained 19.17 points, or 1.41%. The NASDAQ composite index... Read More
category IL0010823792 , Benzinga , Movers , and 9 more.
from Latest Articles from Benzinga.com
StreetInsider.com Pre-Open Movers 11/16: (PENN) (SHF) (OMX) Higher; (DVAX) (SHLD) (SINA) Lower (more...)
November 16, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7886279 for the full story. Read More
from StreetInsider.com News Articles
StreetInsider.com After-Hours Movers 11/15: (SHF) (ARUN) (GPS) Higher; (DVAX) (SHLD) (SINA) Lower (more...)
November 15, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7885336 for the full story. Read More
from StreetInsider.com News Articles
Geron (GERN) Receives non-Binding LoI with BioTime (BTX)
November 15, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7884659 for the full story. Read More
from StreetInsider.com News Articles
4 Biotechnology Stocks to Sell Now
October 17, 2012
 Read More
category Stocks to Sell , AMEX:YMI , NASDAQ:IMGN , and 2 more.
from InvestorPlace - Latest Headlines
BioTime (BTX) Expands Licensing on HyStem-Ccvered Products
August 27, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7686088 for the full story. Read More
from StreetInsider.com News Articles
BioTime (BTX) Publishes Encouraging Data for COL10A1 on Various Types of Human Cancers
August 16, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7666717 for the full story. Read More
from StreetInsider.com News Articles
BioTime (BTX) Files 868K Common Shelf for Shareholders
August 01, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7620376 for the full story. Read More
from StreetInsider.com News Articles
BioTime (BTX) Enters Exclusive Sublicense with Jade Therapeutics for HyStem Hydrogels
July 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7583840 for the full story. Read More
from StreetInsider.com News Articles
BioTime, Inc. (BTX) Widens Q1 Loss to 10c/Share
May 10, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7427092 for the full story. Read More
from StreetInsider.com News Articles
BioTime, Inc. (BTX) Reports Q4 Loss of $0.10
March 14, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7269728 for the full story. Read More
from StreetInsider.com News Articles
BioTime (BTX) to Market Progenitors of Muscle Stem Cells
January 03, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7048638 for the full story. Read More
from StreetInsider.com News Articles
BioTime (BTX) Announces Plans to Begin Producing Stem Cells for Research in Muscle Disorders
January 03, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7048637 for the full story. Read More
from StreetInsider.com News Articles
The Week in Review: Hutchison MediPharma and AstraZeneca Partner on Cancer Drug
December 24, 2011
Hutchison MediPharma and AstraZeneca formed a partnership to develop a novel cancer molecule; Hua Medicine in-licensed global rights to diabetes treatment program; Shunfeng Pharma is auctioning itself... Read More
from ChinaBio® Today
BioTime Options Cell Lines from USCN Life Science China
December 23, 2011
BioTime of the US has signed an agreement with USCN Life Science China, giving BioTime an option to license USCN's antibody-producing cell lines. BioTime and its OncoCyte subsidiary may use the cell... Read More
from ChinaBio® Today
WBB Securities Upgrades BioTime, Inc. (BTX) to Strong Buy
December 19, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7029403 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here